載入...
Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma after Neoadjuvant Therapy as a Prognostic Indicator for Survival
Neoadjuvant therapy has been increasingly used to treat patients with potentially resectable pancreatic ductal adenocarcinoma (PDAC). Although the College of American Pathologists (CAP) grading scheme for tumor response in post-therapy specimens has been used, its clinical significance has not been...
Na minha lista:
| 發表在: | Am J Surg Pathol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5178828/ https://ncbi.nlm.nih.gov/pubmed/27631521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAS.0000000000000738 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|